Smash the mutants
Location: United States
Employees: 11-50
Total raised: $55M
Funding Rounds 2
| Date | Series | Amount | Investors |
| 10.07.2025 | Series A | $45M | Bold Capit... |
| 16.11.2022 | Seed | $10M | - |
Mentions in press and media 9
| Date | Title | Description |
| 11.07.2025 | Centivax Secures $45M to Revolutionize Global Immunity | Centivax closed an oversubscribed $45 million Series A funding round. Future Ventures led the investment. This capital fuels the advancement of Centivax’s lead universal flu vaccine candidate. The vaccine will enter Phase I clinical trials ... |
| 10.07.2025 | Centivax: $45 Million Series A Raised For Advancing Universal Flu Vaccine | Centivax, a biotech firm developing vaccines and therapies for long-lasting, universal protection against diverse targets, announced it has closed an oversubscribed $45 million Series A funding round. Steve Jurvetson of Future Ventures led ... |
| 09.07.2025 | Centivax Raises $45M in Series A Funding | Centivax, a San Francisco, CA-based immunity company providing a proprietary computational immune-engineering platform, raised $45M in Series A funding. The round was led by Steve Jurvetson of Future Ventures, an early backer of Tesla, Spac... |
| 08.07.2025 | Centivax Raises $45M to Commercialize First Universal Flu Vaccine | What You Should Know: – Centivax, a biotech company developing durable, universal vaccines, today announced the close of a $45 million Series A led by Steve Jurvetson’s Future Ventures, with participation from NFX, BOLD Capital, Base4, Kend... |
| 24.06.2025 | Parallel Bio Secures $21 Million to Revolutionize Drug Discovery | In the bustling world of biotechnology, a new player is making waves. Parallel Bio, a Cambridge-based company, has just raised $21 million in Series A funding. This infusion of capital is not just a financial boost; it’s a lifeline for inno... |
| 23.06.2025 | Parallel Bio: $21 Million Series A Raised For Advancing Human-First Drug Discovery | Parallel Bio, a company pioneering human-first drug discovery, announced it has raised $21 million in Series A funding, led by AIX Ventures. The funding round attracted prominent leaders in AI and biotech, including new investors Amplo and ... |
| 04.05.2025 | The Battle for Academia: A Clash of Ideals and Authority | In the heart of America, universities stand as bastions of knowledge. They are the crucibles where ideas are forged and futures are shaped. Yet, a storm brews on the horizon. The autonomy of these institutions is under siege. The clash is n... |
| 02.05.2025 | Snakes have bitten this man hundreds of times. His blood could help make a better treatment | Friede has withstood snakebites and injections for nearly two decades and still has a refrigerator full of venom. In videos posted to his YouTube channel, he shows off swollen fang marks on his arms from black mamba, taipan and water cobra ... |
| - | Centivax | “Centivax” |